U.S., Oct. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07209852) titled 'Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up' on Sept. 29.
Brief Summary: The goal of this observational post-market clinical Follow-up study is to learn about the long-term safety, performance, and clinical benefits of pacing the left bundle branch area (LBBAP) using the INGEVITY+ pacemaker lead in patients with bradycardia who need a pacemaker.
Study Start Date: Jan. 15, 2026
Study Type: OBSERVATIONAL
Condition:
Bradycardia
Atrioventricular Block
Sinus Node Dysfunction
Bundle-Branch Block
Intervention:
DEVICE: Pacemaker lead
The pacemaker lead under investig...